Abstract:Ciprofol (HSK3486) is a novel intravenous agent for general anesthesia. In humans, HSK3486 mainly undergoes glucuronidation to form M4 [fraction of clearance (f CL ): 62.6%], followed by the formation of monohydroxylated metabolites that further undergo glucuronidation and sulfation to produce M5-1, M5-2, M5-3, and M3 (summed f CL : 35.2%). However, the complete metabolic pathways of HSK3486 in humans remain unclear. In this study, by comparison with chemically synthesized reference standards, three monohydroxylated metabolites [M7-1, 4-hydroxylation with an unbound intrinsic clearance (CL int,u ) of 2211 μ l/min/mg; M7-2, -hydroxylation with a CL int,u of 600 μ l/min/mg; and M7-3, (-1)-hydroxylation with a CL int,u of 78.4 μ l/min/mg] were identified in human liver microsomes, and CYP2B6 primarily catalyzed their formation. In humans, M7-1 was shown to undergo glucuronidation at the 4-position and 1-position by multiple UDP-glucuronosyltransferases (UGTs) to produce M5-1 and M5-3, respectively, or was metabolized to M3 by cytosolic sulfotransferases. M7-2 was glucuronidated at the position by UGT1A9, 2B4, and 2B7 to form M5-2. UGT1A9 predominantly catalyzed the glucuronidation of HSK3486 (M4). The CL int,u values for M4 formation in human liver and kidney microsomes were 1028 and 3407 μ l/min/mg, respectively. In vitro to in vivo extrapolation analysis suggested that renal glucuronidation contributed approximately 31.4% of the combined clearance. In addition to HSK3486 glucuronidation (M4), 4-hydroxylation (M7-1) was identified as another crucial oxidative metabolic pathway (f CL : 34.5%). Further attention should be paid to the impact of CYP2B6- and UGT1A9-mediated drug interactions and gene polymorphisms on the exposure and efficacy of HSK3486. SIGNIFICANCE STATEMENT This research elucidates the major oxidative metabolic pathways of HSK3486 (the formation of three monohydroxylated metabolites: M7-1, M7-2, M7-3) as well as definitive structures and formation pathways of these monohydroxylated metabolites and their glucuronides or sulfate in humans. This research also identifies major metabolizing enzymes responsible for the glucuronidation (UGT1A9) and oxidation (CYP2B6) of HSK3486 and characterizes the mechanism of extrahepatic metabolism. The above information is helpful in guiding the safe use of HSK3486 in the clinic.

Human UGT2B7 is the Major Isoform Responsible for the Glucuronidation of Clopidogrel Carboxylate.

CYP450 1A2 and multiple UGT1A isoforms are responsible for jatrorrhizine metabolism in human liver microsomes.

Inter-isoform Hetero-dimerization of Human UDP-Glucuronosyltransferases (ugts) 1A1, 1A9 and 2B7 and Impacts on Glucuronidation Activity

Human uridine diphosphate-glucuronosyltransferase UGT2B7 conjugates mineralocorticoid and glucocorticoid metabolites

The Activity of Members of the UDP-Glucuronosyltransferase Subfamilies UGT1A and UGT2B is Impaired in Patients with Liver Cirrhosis

UGT2B10 is the Major UDP-Glucuronosyltransferase 2B Isoform Involved in the Metabolism of Lamotrigine and is Implicated in the Drug-Drug Interaction with Valproic Acid

Promiscuity and Quantitative Contribution of UGT2B17 in Drug and Steroid Metabolism Determined by Experimental and Computational Approaches

Cytochrome P450 2B6 and UDP-Glucuronosyltransferase Enzyme-Mediated Clearance of Ciprofol in Humans: The Role of Hepatic and Extrahepatic Metabolism

Stereoselective Metabolism of Propranolol Glucuronidation by Human Udp-Glucuronosyltransferases 2b7 and 1A9

Homo- and Hetero-Dimerization of Human UDP-glucuronosyltransferase 2B7 (UGT2B7) Wild Type and Its Allelic Variants Affect Zidovudine Glucuronidation Activity

Uridine 5-Diphosphate Glucuronosyltransferases Involved Metabolism Types and Factors Influencing Glucuronidation

Characterizing the Effect of UDP-glucuronosyltransferase (UGT) 2B7 and UGT1A9 Genetic Polymorphisms on Enantioselective Glucuronidation of Flurbiprofen.

Integrate Thermostabilized Fusion Protein Apocytochrome B 562 RIL and N-glycosylation Mutations: A Novel Approach to Heterologous Expression of Human UDP-glucuronosyltransferase (UGT) 2B7.

Properties of Dietary Flavone Glycosides, Aglycones, and Metabolites on the Catalysis of Human Endoplasmic Reticulum Uridine Diphosphate Glucuronosyltransferase 2B7 (UGT2B7)

Heterodimerization of Human UDP-Glucuronosyltransferase 1A9 and UDP-Glucuronosyltransferase 2B7 Alters Their Glucuronidation Activities.

The Regioselective Glucuronidation of Morphine by Dimerized Human UGT2B7, 1A1, 1A9 and Their Allelic Variants

Catalytic activities of recombinant human uridine 5′-diphosphate glucuronosyltransferases 1A6 on glucuronidation of phenols and carboxylic compounds

Ciprofol is primarily glucuronidated by UGT1A9 and predicted not to cause drug-drug interactions with typical substrates of CYP1A2, CYP2B6, and CYP2C19

A high throughput assay for the glucuronidation of 7-hydroxy-4-trifluoromethylcoumarin by recombinant human UDP-glucuronosyltransferases and liver microsomes

Studies on the Flavonoid Substrates of Human UDP-glucuronosyl Transferase (UGT) 2B7.

Glucuronidation in Humans and Related Factors